Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in Korean patients

Lupus

Volumn 24, Issue 12, 2015, Pages 1342-1349

  Choi, J H ^a   Park, D J ^a   Kang, J H ^a   Yim, Y R ^a   Lee, K E ^a   Lee, J W ^a   Wen, L ^a   Kim, T J ^a   Park, Y W ^a   Lee, J K ^a   Lee, S S ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

age; onset; Systemic lupus erythematosus

Indexed keywords

ALBUMIN; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; C REACTIVE PROTEIN; CENTROMERE ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CREATININE; HEMOGLOBIN; HISTONE ANTIBODY; JO 1 ANTIBODY; LA ANTIBODY; NUCLEOSOME ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SCL 70 ANTIBODY; SERUM ALBUMIN; SM ANTIBODY;

ADOLESCENT; ADULT; ADULT SYSTEMIC LUPUS ERYTHEMATOSUS; ALOPECIA; ANEMIA; ANTIPHOSPHOLIPID SYNDROME; ARTHRALGIA; ARTHRITIS; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE DURATION; DRY EYE; ERYTHROCYTE SEDIMENTATION RATE; ETHNICITY; FEMALE; FEVER; HEMATURIA; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPOTHYROIDISM; JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS; KOREAN (PEOPLE); LATE ONSET SYSTEMIC LUPUS ERYTHEMATOSUS; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; NEPHRITIS; PERICARDITIS; PHOTOSENSITIVITY; PLEURISY; PRIORITY JOURNAL; PROTEINURIA; PURPURA; PYURIA; RASH; RAYNAUD PHENOMENON; SEROLOGY; SJOEGREN SYNDROME; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THYROID DISEASE; XEROSTOMIA; AGE; BLOOD; CHILD; COMPARATIVE STUDY; COMPLICATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; ONSET AGE; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; SOUTH KOREA; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AUTOANTIBODIES; CHILD; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; REPUBLIC OF KOREA; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; YOUNG ADULT;

EID: 84942114743     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203315591024     Document Type: Article

References (40)

1. Von Feldt JM,. Systemic lupus erythematosus. Recognizing its various presentations. Postgrad Med 1995; 97: 79, 83, 86 passim-79, 83, 86 passim.
2. Estes D, Christian CL,. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971; 50: 85-95.
3. Fessler BJ, Boumpas DT,. Severe major organ involvement in systemic lupus erythematosus. Diagnosis and management. Rheum Dis Clin North Am 1995; 21: 81-98.
4. Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME,. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 2010; 9: A277-A287.
5. Fernández M, Alarcón GS, Calvo-Alén J, et al. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum 2007; 57: 576-584.
6. Arbuckle MR, James JA, Dennis GJ, et al. Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus. Lupus 2003; 12: 99-106.
7. Alarcón GS, McGwin G Jr, Petri M, et al. Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 2002; 11: 95-101.
8. Alarcón GS, McGwin G Jr, Roseman JM, et al. Systemic lupus erythematosus in three ethnic groups. XIX. Natural history of the accrual of the American College of Rheumatology criteria prior to the occurrence of criteria diagnosis. Arthritis Rheum 2004; 51: 609-615.
9. Alarcón GS, Calvo-Alén J, McGwin G Jr, et al. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis 2006; 65: 1168-1174.
10. Alarcón GS, McGwin G Jr, Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 2001; 44: 2797-2806.
11. Uribe AG, Alarcón GS,. Ethnic disparities in patients with systemic lupus erythematosus. Curr Rheumatol Rep 2003; 5: 364-369.
12. Samanta A, Feehally J, Roy S, Nichol FE, Sheldon PJ, Walls J,. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991; 50: 490-492.
13. Thumboo J, Uramoto K, O 'Fallon WM, et al. A comparative study of the clinical manifestations of systemic lupus erythematosus in Caucasians in Rochester, Minnesota, and Chinese in Singapore, from 1980 to 1992. Arthritis Rheum 2001; 45: 494-500.
14. Richman IB, Taylor KE, Chung SA, et al. European genetic ancestry is associated with a decreased risk of lupus nephritis. Arthritis Rheum 2012; 64: 3374-3382.
15. Isenberg D, Appel GB, Contreras G, et al. Influence of race/ethnicity on response to lupus nephritis treatment: The ALMS study. Rheumatology 2010; 49: 128-140.
16. Tucker LB, Uribe AG, Fernández M, et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: Results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 2008; 17: 314-322.
17. Boddaert J, Huong DL, Amoura Z, Wechsler B, Godeau P, Piette JC,. Late-onset systemic lupus erythematosus: A personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore) 2004; 83: 348-359.
18. Klein-Gitelman M, Reiff A, Silverman ED,. Systemic lupus erythematosus in childhood. Rheum Dis Clin North Am 2002; 28: 561-577, vi-vii.
19. Carreño L, López-Longo FJ, Monteagudo I, et al. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus 1999; 8: 287-292.
20. Descloux E, Durieu I, Cochat P, et al. Influence of age at disease onset in the outcome of paediatric systemic lupus erythematosus. Rheumatology (Oxford) 2009; 48: 779-784.
21. Faco MM, Leone C, Campos LM, Febrônio MV, Marques HH, Silva CA,. Risk factors associated with the death of patients hospitalized for juvenile systemic lupus erythematosus. Braz J Med Biol Res 2007; 40: 993-1002.
22. Hoffman IE, Lauwerys BR, De Keyser F, et al. Juvenile-onset systemic lupus erythematosus: Different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann Rheum Dis 2009; 68: 412-415.
23. Hersh AO, Trupin L, Yazdany J, et al. Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2010; 62: 1152-1159.
24. Moss KE, Ioannou Y, Sultan SM, Haq I, Isenberg DA,. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis 2002; 61: 409-413.
25. Formiga F, Moga I, Pac M, Mitjavila F, Rivera A, Pujol R,. Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. SLE Disease Activity Index. Lupus 1999; 8: 462-465.
26. Maddison P, Farewell V, Isenberg D, et al. The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol 2002; 29: 913-917.
27. Bertoli AM, Alarcón GS, Calvo-Alén J, et al. Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease. Arthritis Rheum 2006; 54: 1580-1587.
28. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
29. Hochberg MC,. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725-1725.
30. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311.
31. American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care 2012; 35 (Suppl 1): S11-S63.
32. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren 's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-558.
33. Gladman DD, Ibañez D, Urowitz MB,. Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol 2002; 29: 288-291.
34. Amaral B, Murphy G, Ioannou Y, Isenberg DA,. A comparison of the outcome of adolescent and adult-onset systemic lupus erythematosus. Rheumatology 2014; 53: 1130-1135.
35. Chen YM, Lin CH, Chen HH, et al. Onset age affects mortality and renal outcome of female systemic lupus erythematosus patients: A nationwide population-based study in Taiwan. Rheumatology 2014; 53: 180-185.
36. Feng X, Zou Y, Pan W, et al. Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus. Lupus 2014; 23: 327-334.
37. Merola J, Bermas B, Lu B, et al. Clinical manifestations and survival among adults with (SLE) according to age at diagnosis. Lupus 2014; 23: 778-784.
38. Simón JA, Cabiedes J, Ortiz E, Alcocer-Varela J, Sánchez-Guerrero J,. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker. Rheumatology 2004; 43: 220-224.
39. Suleiman S, Kamaliah D, Nadeem A, Naing NN, Che Maraina CH,. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus. Int J Rheum Dis 2009; 12: 100-106.
40. Font J, Cervera R, Espinosa G, et al. Systemic lupus erythematosus (SLE) in childhood: Analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 1998; 57: 456-459.